Aspartame is an artificial sweetener that is calorie-free. The safety of aspartame has long been a controversial topic in the medical world. Although several studies show that aspartame is safe for consumption, there is evidence of its potential link to fibromyalgia. In fact, aspartame is also link to other chronic conditions.
Aspartame is one of the six artificial sweeteners approved for use by the US FDA. The sweeteners have a sweetening capacity that is several times sweeter than sugar. FDA reviewed each sweetener thoroughly especially in terms of health safety. In fact, the safety testing went beyond the required testing level for food additives, according to a study published in Regulatory Toxicology and Pharmacology. The authors of the article concluded that aspartame is safe for everyone to consume.
There is no existing study done to determine if aspartame can trigger fibromyalgia. However, a 2010 article published in Clinical and Experimental Rheumatology, reported two different cases. These cases were reports on two individuals who had fibromyalgia and whose symptoms had vanished after they stopped consuming aspartame.
One of the cases follows a 50-year-old woman who suffered from fibromyalgia for more than 10 years. She went on a vacation for several days without taking any aspartame. During her vacation, her fibromyalgia symptoms were nonexistent. Thereafter, she decided to totally remove aspartame from her diet. After which, she saw complete regression of all her fibro symptoms.
Since the cause of fibromyalgia is not known, the manner by which these individuals experienced regression of symptoms can only be speculated. Yet, many believe that fibro patients can benefit from eliminating aspartame from their diet. The potential benefit of eliminating this sweetener from their diet can be a reduction of symptoms. This is not only applicable to those suffering from fibromyalgia but also to people with other chronic diseases.
Fibromyalgia is still seen as less than legitimate in the medical world. Fortunately, some researchers believe otherwise and many are working on various approaches in treating the condition. The recent drug which received a fast track status from the FDA is IMC-1. This drug is a type of viral suppression drug that showed promising results in treating fibromyalgia.
As mentioned, IMC-1 is a type of viral suppression drug invented and studied by Innovative Med Concepts (IMC) for the treatment of fibromyalgia. The main purpose of the drug is to suppress viruses in the body. The theory behind IMC-1 is that chronic pain syndrome may be related to the herpes virus, which lies dormant in the body tissues. Researchers observed that fibromyalgia exhibit the same symptoms as other diseases linked to herpes.
They believed that the dormant herpes virus may play a part in triggering and maintaining the symptoms of fibromyalgia. One of the most common fibro symptoms is widespread chronic pain. Others are sleep problems, overwhelming fatigue, and mood problems. Many fibro patients may also suffer from frequent headaches, IBS, and cognitive impairment, famously known as fibro fog.
IMC-1 is a combination of anti-viral famciclovir and anti-inflammatory celecoxib. The basis of using the drug as treatment is its potential effectiveness in suppressing the herpes virus. Currently, the drug has already completed Phase 2 trials, a double-blinded and placebo-controlled study done by some experts in the medical field.
In the study, 143 fibromyalgia participants were randomly given either IMC-1 or a placebo over a 16-week treatment period. Researchers observed and evaluated the participants during the 16 weeks. At the end of the study, participants who took IMC-1 showed less fibromyalgia pain and lower pain scores. This group also reported less fatigue. In general, participants tolerated the drug well.
This study showed a potential treatment option for the pain and symptoms of fibromyalgia. It also suggests that suppressing the dormant herpes virus can improve chronic pain syndrome. This finding may lead to more clues to the root of fibromyalgia. IMC is now coordinating with FDA in order to comply with the requirements needed for the Phase 3 trial which is targeted to commence end of 2017.
Although there are around 5 million fibro patients in America, it was only in the recent decade that chronic pain syndrome gain awareness. There is no definitive fluid test or scans that can confirm the diagnosis and limited options for treatment. This lack of effective treatment is the reason why FDA has granted the Fast Track designation to IMC-1. This designation further encourages drug development for such disease, which doesn’t have many treatment options.
Treating some of the most common symptoms of fibromyalgia will require the use of certain drugs. Among these are painkillers, antidepressants, Lyrica, and many more. Doctors also recommend regular exercise, a proper diet, and getting enough sleep. However, what most fibro patients need is an even quicker and more effective relief from its debilitating symptoms.
For More Information Related Fibromyalgia Visit below sites:
Fibromyalgia Contact Us Directly
Fibro Women Blogs
Chronic Woman Blogs
Chronic Illness Blogs
Official Fibromyalgia Blogs